Blog

Toronto, Ontario – November 8, 2016 – NOVADAQ Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant, fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that Rick Mangat, President and Chief Executive Officer, is scheduled to present at the Canaccord Genuity Medical Technologies and … Continue reading “NOVADAQ to Present at the Canaccord Genuity Medical Technologies and Diagnostics Forum”

NOVADAQ Reports Third Quarter 2016 Financial Results  Toronto, Ontario – November 2, 2016 – NOVADAQ Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced financial results for its third quarter ended September 30, 2016. Unless otherwise … Continue reading “NOVADAQ Reports Third Quarter 2016 Financial Results”

TORONTO, Oct. 20, 2016 (GLOBE NEWSWIRE) — NOVADAQ Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ) (TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, will announce financial results for the third quarter of 2016 after market close on Wednesday, November 2, 2016. NOVADAQ President and … Continue reading “NOVADAQ to Release Third Quarter 2016 Financial Results on November 2, 2016—Conference Call to Follow”

Toronto, Ontario – September 6, 2016 – NOVADAQ Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that Karen A. Licitra will be joining the Company’s Board of Directors. Ms. Licitra has a track record of accomplishments in sales, … Continue reading “NOVADAQ Announces Appointment of Karen A. Licitra to its Board of Directors”

Toronto, Ontario – August 25, 2016 – NOVADAQ Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that management will present an update on the Company’s business at the 2016 Morgan Stanley Global Healthcare Conference on Monday, September 12, … Continue reading “NOVADAQ to Present at the 2016 Morgan Stanley Global Healthcare Conference”

Toronto, Ontario – July 29, 2016 – NOVADAQ Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that management will participate in two investor conferences in August. Canaccord Genuity 36th Annual Growth Conference: NOVADAQ is scheduled to present on … Continue reading “NOVADAQ to Participate in August Investor Conferences”

Toronto, Ontario – July 27, 2016 – NOVADAQ Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, today announced financial results for its second quarter ended June 30, 2016. Unless otherwise indicated, all dollar amounts in this press release are expressed … Continue reading “NOVADAQ Reports Second Quarter 2016 Financial Results”

Toronto, Ontario – July 11, 2016 – NOVADAQ Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, will announce financial results for the second quarter of 2016 after market close on Wednesday, July 27, 2016. NOVADAQ President and CEO, Rick Mangat … Continue reading “NOVADAQ to Release Second Quarter 2016 Financial Results on July 27, 2016 – Conference Call to Follow”

Toronto, Ontario – July 6, 2016 – NOVADAQ® Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, announced today the appointment of Rick Mangat, Ph.D. as its President and CEO. Dr. Mangat succeeds Arun Menawat, who has resigned as the Company’s President, … Continue reading “NOVADAQ Announces Appointment of Rick Mangat as President and CEO”

Toronto, Ontario – May 20, 2016 – NOVADAQ® Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures, announced that at the annual meeting (the “Meeting”) of shareholders of the Company (the “Shareholders”) that was held on May 18, 2016, all seven (7) … Continue reading “NOVADAQ REPORTS VOTING RESULTS FROM ANNUAL MEETING OF SHAREHOLDERS”